← back to search

Witold Rużyłło

Narodowy Instytut Leków · PL
Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Coronary Interventions and Diagnostics, Cardiac Imaging and Diagnostics, Acute Myocardial Infarction Research, and Cardiac Valve Diseases and Treatments.
h-index
49
citations
27,457
works
229
NIH funding
primary concept
Medicine
email

Recent publications

Impact of Complete Revascularization in the ISCHEMIA Trial
Journal of the American College of Cardiology 2023cited by 44position: middledoi
Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry
European Heart Journal 2023cited by 30position: middledoi
Reintervention and Survival After Transcatheter Pulmonary Valve Replacement
Journal of the American College of Cardiology 2022cited by 64position: middledoi
Initial Invasive or Conservative Strategy for Stable Coronary Disease
New England Journal of Medicine 2020cited by 2,362position: middledoi
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial
JAMA Cardiology 2019cited by 132position: middledoi
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial
Journal of the American Heart Association 2018cited by 85position: middledoi
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes
Journal of the American College of Cardiology 2016cited by 108position: middledoi
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine
JAMA Cardiology 2016cited by 96position: middledoi
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
New England Journal of Medicine 2015cited by 4,366position: middledoi
Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery
Journal of the American College of Cardiology 2013cited by 43position: middledoi
Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
New England Journal of Medicine 2012cited by 869position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kurt Huber · FWF Austrian Science Fund4 papers (2013–2018)Harvey D. White · University of Auckland3 papers (2013–2019)Lars Wallentin · Uppsala University3 papers (2013–2016)Renato D. Lópes · Alnylam Pharmaceuticals (United States)3 papers (2016–2019)Claes Held · Uppsala University3 papers (2013–2018)Kenneth W. Mahaffey · Stanford University2 papers (2013–2016)David J. Moliterno · University of Kentucky2 papers (2013–2016)Sigrun Halvorsen · Oslo University Hospital2 papers (2016–2018)Pascal Vranckx · Fujita Health University2 papers (2013–2016)Robert A. Harrington · Duke University2 papers (2013–2016)John H. Alexander · Duke University Hospital2 papers (2016–2018)Frans Van de Werf · KU Leuven2 papers (2013–2016)Ziad Hijazi · Uppsala University2 papers (2016–2018)Zhen Huang · Zhejiang Chinese Medical University2 papers (2013–2016)José Carlos Nicolau · Beth Israel Deaconess Medical Center2 papers (2013–2016)Michael G. Hanna · Murdoch Children's Research Institute2 papers (2016–2018)Christopher B. Granger · Duke University2 papers (2016–2018)Paul W. Armstrong · Canadian Armed Forces2 papers (2013–2016)Pierluigi Tricoci · New York University2 papers (2013–2016)Philip E. Aylward · South Australian Health and Medical Research Institute2 papers (2013–2016)